Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
07/2011
07/12/2011US7977464 Antibody molecules specific to human tumour necrosis factor alpha
07/12/2011US7977463 Erythropoietin producing hepatocellular receptor (EphB4) specific immunoglobulins for use in diagnosis prevention and treatment of cell proliferative disorders
07/12/2011US7977462 Tyrosine phosphorylation sites
07/12/2011US7977317 Compositions and methods for modulating blood-brain barrier transport
07/12/2011US7977316 Prevention and treatment of amyloidogenic diseases
07/12/2011US7977312 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures
07/12/2011US7977082 Sucrose isomerases for use in production of isomaltulose from sucrose; sugar substitute
07/12/2011US7977071 Binding moieties based on shark ignar domains
07/12/2011US7977068 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
07/12/2011US7977067 Using fungal host as bioreactor for production of monoclonal antibodies
07/12/2011US7977062 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
07/12/2011US7977060 Mammalian sweet taste receptors
07/12/2011US7977059 17867, a novel human aminopeptidase
07/12/2011US7977047 Delete sequence in M. tuberculosis, method for detecting mycobacteria using these sequences and vaccines
07/12/2011US7976868 Liposomes comprising duramycin and anti-viral agents
07/12/2011US7976849 Hepatitis-C virus testing
07/12/2011US7976841 Anti TfR antibody
07/12/2011US7976840 Use of anti-GL50 antibodies for the downmodulation of an immune response
07/12/2011US7976838 Therapy of autoimmune disease in a patient with an inadequate response to a TNF-α inhibitor
07/12/2011CA2480162C Induction of anti-tumor ctl immunity through in vivo triggering of 4-1bb and/or cd40
07/12/2011CA2470711C Novel n-acetylglucosamine transferase, nucleic acid encoding the same, antibody against the same and use thereof for diagnosing cancer or tumor
07/12/2011CA2463616C Affinity enhancement agents
07/12/2011CA2457763C Method and apparatus for separation of milk, colostrum, and whey
07/12/2011CA2419148C Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods
07/12/2011CA2312274C Isolated dna encoding human h3 histamine receptor
07/12/2011CA2220442C Chromatin regulator genes
07/12/2011CA2162555C Method for the culture in vitro of different stages of tissue parasites
07/07/2011WO2011082345A2 Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof
07/07/2011WO2011081898A1 Membranes and associated methods for purification of antibodies
07/07/2011WO2011081421A2 Complement c9 as markers for the diagnosis of cancer
07/07/2011WO2011081366A2 Beef-specific age determination marker containing the p21 protein
07/07/2011WO2011081189A1 Anti-iga1 antibody
07/07/2011WO2011081164A1 Anti-cd27 antibody
07/07/2011WO2011080796A1 Anti-cdh3 antibodies and uses thereof
07/07/2011WO2011080698A1 Process for the industrial - scale purification of gamma globulins from human plasma for industrial applications
07/07/2011WO2011080401A1 Receptor tyrosine kinase-binding compositions
07/07/2011WO2011080350A1 Humanized antibodies
07/07/2011WO2011080322A1 Method of prognosing the outcome of acquired hemophilia and of treatment of hemophilia
07/07/2011WO2011080050A2 Binding molecules
07/07/2011WO2011079902A2 Biological materials and uses thereof
07/07/2011WO2011060246A3 A method of promoting dendritic spine density
07/07/2011WO2011051726A3 Treatment of obesity
07/07/2011WO2011050985A8 Clonal expansion of b cells
07/07/2011WO2011045080A3 Monoclonal antibodies to progastrin and their uses
07/07/2011WO2011036183A3 Anti-cd33 antibodies and use thereof for immunotargeting in treating cd33-associated illnesses
07/07/2011WO2011008092A4 Gram-positive bacteria specific binding compounds
07/07/2011WO2010077854A8 High affinity human antibodies to pcsk9
07/07/2011US20110166844 Systems and Methods for Antibody Engineering
07/07/2011US20110166331 Il-17 receptor a antigen binding proteins
07/07/2011US20110166330 GPCR crystalization method using an antibody
07/07/2011US20110166329 Combinations of SAP depleting agents and anti-SAP antibodies
07/07/2011US20110166328 Avian Antibodies Specific to Influenza Virus and Technologically Simple Methods of Their Manufacture and Use
07/07/2011US20110166327 Apheresis device
07/07/2011US20110166076 Antigen-binding proteins that inhibit superantigens for the treatment of skin diseases
07/07/2011US20110166075 Method of treating degenerative disorders of the nervous system by administration of fibrinogen fragment
07/07/2011US20110166066 Catestatin (cst) and its variants for treatment of cardiovascular and metabolic disorders
07/07/2011US20110166043 Biomarker detection-2
07/07/2011US20110165701 Monoclonal antibody and immunoassay using the same
07/07/2011US20110165699 Irinotecan immunoassay
07/07/2011US20110165659 Biological products
07/07/2011US20110165621 Humanized antibodies
07/07/2011US20110165599 Monoclonal antibody therapy for pancreas cancer
07/07/2011US20110165592 Antibodies against human epo receptor
07/07/2011US20110165588 Method for quantifying phosphokinase activity on proteins
07/07/2011US20110165184 Cdh3 peptide and medicinal agent comprising the same
07/07/2011US20110165180 Polypeptides capable of binding to CD64 comprising one or more heterologous T cell epitopes and their uses
07/07/2011US20110165178 Diagnosis of prostate cancer
07/07/2011US20110165177 Methods of Modulating Immunity
07/07/2011US20110165175 Antibody of human origin for inhibiting thrombocytes aggregation
07/07/2011US20110165173 Therapeutic agent and detection reagent for arteriosclerotic disease which targets for salusin
07/07/2011US20110165170 Osteopontin antibodies
07/07/2011US20110165169 Complement inhibitors and uses thereof
07/07/2011US20110165168 Cidea modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
07/07/2011US20110165166 Lsr receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications
07/07/2011US20110165165 Mammalian genes; related reagents and methods
07/07/2011US20110165164 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
07/07/2011US20110165161 Anti-epcam antibodies that induce apoptosis of cancer cells and methods using same
07/07/2011US20110165160 Neutrokine-alpha and neutrokine-alpha splice variant
07/07/2011US20110165159 Use of chimeric anti-cd20 antibody as in vitro or in vivo purging agent in patients receiving bmt or pbsc transplant
07/07/2011US20110165158 Methods for the therapy of inflammatory bowel disease using a type-1 interferon antagonist
07/07/2011US20110165156 Antibodies against human csf-1r and uses thereof
07/07/2011US20110165153 Anti cd37 antibodies
07/07/2011US20110165148 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
07/07/2011US20110165147 Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor
07/07/2011US20110165145 Igf-ii/igf-iie binding proteins
07/07/2011US20110165081 Psma antibodies and uses thereof
07/07/2011US20110165080 Monoclonal antibodies and their use
07/07/2011US20110165078 Specific binding members against synaptophysin
07/07/2011US20110165073 Immunotherapy of b-cell malignancies using anti-cd22 antibodies
07/07/2011US20110165071 Methods Of Treating Cancer
07/07/2011US20110165066 Interleukin-13 binding proteins
07/07/2011US20110165063 Il-1 binding proteins
07/07/2011US20110165062 Use of an anti-cd151 antibody for early treatment of cancer
07/07/2011CA2789196A1 Anti-iga1 antibody
07/07/2011CA2785964A1 Anti-cd27 antibody
07/07/2011CA2785825A1 Process for the industrial-scale purification of gamma globulins from human plasma for industrial applications
07/07/2011CA2784767A1 Humanized antibodies
07/07/2011CA2780819A1 Membranes and associated methods for purification of antibodies
07/06/2011EP2341144A1 Interleukin-17 related mammalian cytokines. Polynucleotides encoding them. Uses
07/06/2011EP2341143A1 OX2 receptor homolog